Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Hviid Simonsen

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Plos One|January 12, 2026
Blood-brain barrier integrity and prevalence of intrathecal T helper 17.1 cells in Huntington´s diseaseBirna Ásbjörnsdóttir, Christian Sandøe Musaeus, Marie N N Hellem, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersHanna Huber, Wagner Scheeren Brum, Laia Montoliu-Gaya, et al.
Biomarkers in Medicine|August 25, 2012
Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an updateMarta del Campo, Brit Mollenhauer, Antonio Bertolotto, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 31, 2024
Guidelines for the standardization of pre-analytical variables for salivary biomarker studies in Alzheimer's disease research: An updated review and consensus of the Salivary Biomarkers for Dementia Research Working GroupTed K S Ng, Chinedu Udeh-Momoh, Mei-Ann Lim, et al.
Frontiers in Neuroscience|March 6, 2023
Golgi fragmentation - One of the earliest organelle phenotypes in Alzheimer's disease neuronsHenriette Haukedal, Giulia I Corsi, Veerendra P Gadekar, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 26, 2017
Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementiaAnja Hviid Simonsen, Sanna-Kaisa Herukka, Niels Andreasen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 26, 2017
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairmentSanna-Kaisa Herukka, Anja Hviid Simonsen, Niels Andreasen, et al.
Journal of Alzheimer'S Disease : JAD|October 16, 2018
Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid BiomarkersMafalda Ramos de Matos, Catarina Ferreira, Sanna-Kaisa Herukka, et al.
Frontiers in Neurology|November 4, 2015
The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative DiseasesBabette L R Reijs, Charlotte E Teunissen, Nikolai Goncharenko, et al.
Nature Medicine|February 16, 2026
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disordersKatharina Bolsewig, Giovanni Bellomo, Yanaika S Hok-A-Hin, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Plos One|January 12, 2026
Blood-brain barrier integrity and prevalence of intrathecal T helper 17.1 cells in Huntington´s diseaseBirna Ásbjörnsdóttir, Christian Sandøe Musaeus, Marie N N Hellem, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
BiomarkersHanna Huber, Wagner Scheeren Brum, Laia Montoliu-Gaya, et al.
Biomarkers in Medicine|August 25, 2012
Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an updateMarta del Campo, Brit Mollenhauer, Antonio Bertolotto, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 31, 2024
Guidelines for the standardization of pre-analytical variables for salivary biomarker studies in Alzheimer's disease research: An updated review and consensus of the Salivary Biomarkers for Dementia Research Working GroupTed K S Ng, Chinedu Udeh-Momoh, Mei-Ann Lim, et al.
Frontiers in Neuroscience|March 6, 2023
Golgi fragmentation - One of the earliest organelle phenotypes in Alzheimer's disease neuronsHenriette Haukedal, Giulia I Corsi, Veerendra P Gadekar, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 26, 2017
Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementiaAnja Hviid Simonsen, Sanna-Kaisa Herukka, Niels Andreasen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 26, 2017
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairmentSanna-Kaisa Herukka, Anja Hviid Simonsen, Niels Andreasen, et al.
Journal of Alzheimer'S Disease : JAD|October 16, 2018
Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid BiomarkersMafalda Ramos de Matos, Catarina Ferreira, Sanna-Kaisa Herukka, et al.
Frontiers in Neurology|November 4, 2015
The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative DiseasesBabette L R Reijs, Charlotte E Teunissen, Nikolai Goncharenko, et al.
Nature Medicine|February 16, 2026
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disordersKatharina Bolsewig, Giovanni Bellomo, Yanaika S Hok-A-Hin, et al.
Pageof 10